Interventional Radiology Market by Product (MRI System, Ultrasound Imaging System, CT Scanner, Angiography System), Procedures (Angiography, Angioplasty, Biopsy) & Application (Cardiology, Oncology, Urology & Nephrology) - Global Forecast to 2021
The global interventional radiology imaging market is expected to reach USD 23.50 billion by 2021 from USD 16.99 billion in 2016, at a CAGR of 6.7%. The market is broadly classified into product, procedures, and application.
On the basis of product, the market is segmented into angiography systems, fluoroscopy systems, CT scanners, ultrasound-imaging systems, MRI system, and other devices (C-arm, contrast media injectors, & imaging catheter guidewires). The MRI system segment is estimated to account for the largest share of the market in 2016. Factors such as technological advancements and product launches are driving the growth of this segment.
Based on procedure, the market is segmented into angiography, angioplasty, embolization, thrombolysis, vertebroplasty, nephrostomy, and other procedures (biliary drainage, fallopian tube recanalization, cholecystectomy, and carotid-cavernous fistula). The angiography segment is projected to witness the highest growth in this market due to increasing prevalence of cardiovascular diseases and the growing demand for minimally invasive procedures.
By applications, the market is segmented into cardiology, oncology, urology & nephrology, gastroenterology, and other applications (orthopedics, neurology, and gynecology). The oncology segment is projected to witness the highest growth in this market due to increase in the incidence of cancer and rising demand for minimally invasive procedures.
Geographically, the market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American region is primarily driven by the increase in the prevalence and incidence of chronic diseases and the aging population.
The key players in the market include GE Healthcare (General Electric Company) (U.K.), Siemens Healthcare GmBH (Siemens AG) (Germany), Koninklijke Philips N.V. (The Netherlands), Toshiba Medical Systems Corporation (Toshiba Corporation) (Japan), Hitachi Medical Corporation (Hitachi Ltd.) (Japan), Carestream Health, Inc. (U.S.), Esaote S.p.A (Italy), Hologic, Inc. (U.S.), Fujifilm Corporation (Japan), Samsung Medison (South Korea), and Shimadzu Corporation (Japan).
Research Coverage:
Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The abovementioned market research data, current market size, and forecast of the future trends will help market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market.
Reasons to Buy the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies to strengthen their market shares.
The report provides insights on the following pointers:
On the basis of product, the market is segmented into angiography systems, fluoroscopy systems, CT scanners, ultrasound-imaging systems, MRI system, and other devices (C-arm, contrast media injectors, & imaging catheter guidewires). The MRI system segment is estimated to account for the largest share of the market in 2016. Factors such as technological advancements and product launches are driving the growth of this segment.
Based on procedure, the market is segmented into angiography, angioplasty, embolization, thrombolysis, vertebroplasty, nephrostomy, and other procedures (biliary drainage, fallopian tube recanalization, cholecystectomy, and carotid-cavernous fistula). The angiography segment is projected to witness the highest growth in this market due to increasing prevalence of cardiovascular diseases and the growing demand for minimally invasive procedures.
By applications, the market is segmented into cardiology, oncology, urology & nephrology, gastroenterology, and other applications (orthopedics, neurology, and gynecology). The oncology segment is projected to witness the highest growth in this market due to increase in the incidence of cancer and rising demand for minimally invasive procedures.
Geographically, the market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American region is primarily driven by the increase in the prevalence and incidence of chronic diseases and the aging population.
The key players in the market include GE Healthcare (General Electric Company) (U.K.), Siemens Healthcare GmBH (Siemens AG) (Germany), Koninklijke Philips N.V. (The Netherlands), Toshiba Medical Systems Corporation (Toshiba Corporation) (Japan), Hitachi Medical Corporation (Hitachi Ltd.) (Japan), Carestream Health, Inc. (U.S.), Esaote S.p.A (Italy), Hologic, Inc. (U.S.), Fujifilm Corporation (Japan), Samsung Medison (South Korea), and Shimadzu Corporation (Japan).
Research Coverage:
Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The abovementioned market research data, current market size, and forecast of the future trends will help market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market.
Reasons to Buy the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies to strengthen their market shares.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the interventional radiology imaging market. The report analyses the interventional radiology imaging market: by product, by procedure, and by application.
- Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the interventional radiology imaging market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the interventional radiology imaging market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various interventional radiology imaging products across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the interventional radiology imaging market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKET COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 SECONDARY DATA
2.1.1 KEY DATA FROM SECONDARY SOURCES
2.2 PRIMARY DATA
2.2.1 KEY DATA FROM PRIMARY SOURCES
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
3.1 INTRODUCTION
3.2 CONCLUSION
4 PREMIUM INSIGHTS
4.1 INTERVENTIONAL RADIOLOGY: MARKET OVERVIEW
4.2 INTERVENTIONAL RADIOLOGY MARKET, BY PRODUCT AND REGION (2016)
4.3 LIFE CYCLE ANALYSIS, BY REGION
5 INDUSTRY INSIGHTS
5.1 INTRODUCTION
5.2 PORTER’S FIVE FORCES ANALYSIS
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 THREAT OF SUBSTITUTES
5.2.3 BARGAINING POWER OF BUYERS
5.2.4 BARGAINING POWER OF SUPPLIERS
5.2.5 INTENSITY OF RIVALRY
5.3 SUPPLY CHAIN ANALYSIS
5.4 KEY INFLUENCERS
6 MARKET OVERVIEW
6.1 INTRODUCTION
6.2 MARKET DYNAMICS
6.2.1 DRIVERS
6.2.1.1 Rising incidence and prevalence of chronic diseases
6.2.1.2 Increasing demand for minimally invasive procedures
6.2.1.3 Technological advancements in Interventional Radiology devices
6.2.2 RESTRAINTS
6.2.2.1 Risk of high radiation exposure to limit the use of CT scanners
6.2.2.2 Shortage of Helium - a major concern for MRI manufacturers and healthcare facilities
6.2.3 OPPORTUNITIES
6.2.3.1 Emerging markets
6.2.4 CHALLENGES
6.2.4.1 Entry barriers for new players
6.2.4.2 Hospital budget cuts
6.2.4.3 Increasing adoption of refurbished Interventional Radiology systems
7 INTERVENTIONAL RADIOLOGY MARKET, BY PRODUCT
7.1 INTRODUCTION
7.2 MRI SYSTEMS
7.3 ULTRASOUND IMAGING SYSTEMS
7.4 CT SCANNERS
7.5 ANGIOGRAPHY SYSTEMS
7.6 FLUOROSCOPY SYSTEMS
7.7 BIOPSY DEVICES
7.8 OTHER DEVICES
8 INTERVENTIONAL RADIOLOGY MARKET, BY PROCEDURE
8.1 INTRODUCTION
8.2 ANGIOGRAPHY
8.3 ANGIOPLASTY
8.4 BIOPSY AND DRAINAGE
8.5 EMBOLIZATION
8.6 THROMBOLYSIS
8.7 VERTEBROPLASTY
8.8 NEPHROSTOMY
8.9 OTHER PROCEDURES
9 INTERVENTIONAL RADIOLOGY MARKET, BY APPLICATION
9.1 INTRODUCTION
9.2 CARDIOLOGY
9.3 UROLOGY & NEPHROLOGY
9.4 ONCOLOGY
9.5 GASTROENTEROLOGY
9.6 OTHER APPLICATIONS
10 INTERVENTIONAL RADIOLOGY MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 U.S.
10.2.2 CANADA
10.3 EUROPE
10.3.1 GERMANY
10.3.2 FRANCE
10.3.3 U.K.
10.3.4 ITALY
10.3.5 REST OF EUROPE
10.4 ASIA
10.5 REST OF THE WORLD (ROW)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 MARKET SHARE ANALYSIS
11.3 COMPETITIVE SITUATION AND TRENDS
11.3.1 PRODUCT LAUNCHES
11.3.2 AGREEMENTS, COLLABORATIONS & PARTNERSHIPS
11.3.3 APPROVALS
11.3.4 EXPANSIONS
11.3.5 ACQUISITIONS
11.3.6 OTHER DEVELOPMENTS
12 COMPANY PROFILE
(Overview, Products and Services, Financials, Strategy & Development)*
12.1 INTRODUCTION
12.2 GE HEALTHCARE (A FULLY OWNED SUBSIDIARY OF GENERAL ELECTRIC COMPANY)
12.3 SIEMENS AG
12.4 KONINKLIJKE PHILIPS N.V.
12.5 TOSHIBA MEDICAL SYSTEMS CORPORATION (TOSHIBA CORPORATION)
12.6 HITACHI MEDICAL CORPORATION (HITACHI LTD.)
12.7 CARESTREAM HEALTH
12.8 ESAOTE S.P.A.
12.9 HOLOGIC INC.
12.10 SHIMADZU CORPORATION
12.11 SAMSUNG MEDISON
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.
13 APPENDIX
13.1 INDUSTRY INSIGHTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
13.5 AVAILABLE CUSTOMIZATIONS
13.6 RELATED REPORTS
13.7 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKET COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 SECONDARY DATA
2.1.1 KEY DATA FROM SECONDARY SOURCES
2.2 PRIMARY DATA
2.2.1 KEY DATA FROM PRIMARY SOURCES
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
3.1 INTRODUCTION
3.2 CONCLUSION
4 PREMIUM INSIGHTS
4.1 INTERVENTIONAL RADIOLOGY: MARKET OVERVIEW
4.2 INTERVENTIONAL RADIOLOGY MARKET, BY PRODUCT AND REGION (2016)
4.3 LIFE CYCLE ANALYSIS, BY REGION
5 INDUSTRY INSIGHTS
5.1 INTRODUCTION
5.2 PORTER’S FIVE FORCES ANALYSIS
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 THREAT OF SUBSTITUTES
5.2.3 BARGAINING POWER OF BUYERS
5.2.4 BARGAINING POWER OF SUPPLIERS
5.2.5 INTENSITY OF RIVALRY
5.3 SUPPLY CHAIN ANALYSIS
5.4 KEY INFLUENCERS
6 MARKET OVERVIEW
6.1 INTRODUCTION
6.2 MARKET DYNAMICS
6.2.1 DRIVERS
6.2.1.1 Rising incidence and prevalence of chronic diseases
6.2.1.2 Increasing demand for minimally invasive procedures
6.2.1.3 Technological advancements in Interventional Radiology devices
6.2.2 RESTRAINTS
6.2.2.1 Risk of high radiation exposure to limit the use of CT scanners
6.2.2.2 Shortage of Helium - a major concern for MRI manufacturers and healthcare facilities
6.2.3 OPPORTUNITIES
6.2.3.1 Emerging markets
6.2.4 CHALLENGES
6.2.4.1 Entry barriers for new players
6.2.4.2 Hospital budget cuts
6.2.4.3 Increasing adoption of refurbished Interventional Radiology systems
7 INTERVENTIONAL RADIOLOGY MARKET, BY PRODUCT
7.1 INTRODUCTION
7.2 MRI SYSTEMS
7.3 ULTRASOUND IMAGING SYSTEMS
7.4 CT SCANNERS
7.5 ANGIOGRAPHY SYSTEMS
7.6 FLUOROSCOPY SYSTEMS
7.7 BIOPSY DEVICES
7.8 OTHER DEVICES
8 INTERVENTIONAL RADIOLOGY MARKET, BY PROCEDURE
8.1 INTRODUCTION
8.2 ANGIOGRAPHY
8.3 ANGIOPLASTY
8.4 BIOPSY AND DRAINAGE
8.5 EMBOLIZATION
8.6 THROMBOLYSIS
8.7 VERTEBROPLASTY
8.8 NEPHROSTOMY
8.9 OTHER PROCEDURES
9 INTERVENTIONAL RADIOLOGY MARKET, BY APPLICATION
9.1 INTRODUCTION
9.2 CARDIOLOGY
9.3 UROLOGY & NEPHROLOGY
9.4 ONCOLOGY
9.5 GASTROENTEROLOGY
9.6 OTHER APPLICATIONS
10 INTERVENTIONAL RADIOLOGY MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 U.S.
10.2.2 CANADA
10.3 EUROPE
10.3.1 GERMANY
10.3.2 FRANCE
10.3.3 U.K.
10.3.4 ITALY
10.3.5 REST OF EUROPE
10.4 ASIA
10.5 REST OF THE WORLD (ROW)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 MARKET SHARE ANALYSIS
11.3 COMPETITIVE SITUATION AND TRENDS
11.3.1 PRODUCT LAUNCHES
11.3.2 AGREEMENTS, COLLABORATIONS & PARTNERSHIPS
11.3.3 APPROVALS
11.3.4 EXPANSIONS
11.3.5 ACQUISITIONS
11.3.6 OTHER DEVELOPMENTS
12 COMPANY PROFILE
(Overview, Products and Services, Financials, Strategy & Development)*
12.1 INTRODUCTION
12.2 GE HEALTHCARE (A FULLY OWNED SUBSIDIARY OF GENERAL ELECTRIC COMPANY)
12.3 SIEMENS AG
12.4 KONINKLIJKE PHILIPS N.V.
12.5 TOSHIBA MEDICAL SYSTEMS CORPORATION (TOSHIBA CORPORATION)
12.6 HITACHI MEDICAL CORPORATION (HITACHI LTD.)
12.7 CARESTREAM HEALTH
12.8 ESAOTE S.P.A.
12.9 HOLOGIC INC.
12.10 SHIMADZU CORPORATION
12.11 SAMSUNG MEDISON
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.
13 APPENDIX
13.1 INDUSTRY INSIGHTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
13.5 AVAILABLE CUSTOMIZATIONS
13.6 RELATED REPORTS
13.7 AUTHOR DETAILS
LIST OF TABLES
Table 1 INTERVENTIONAL RADIOLOGY MARKET SUMMARY
Table 2 INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 3 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR MRI SYSTEMS, BY REGION, 2014–2021 (USD MILLION)
Table 4 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE FOR ULTRASOUND SYSTEMS, BY REGION, 2014–2021 (USD MILLION)
Table 5 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR CT SCANNERS, BY REGION, 2014–2021 (USD MILLION)
Table 6 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR ANGIOGRAPHY SYSTEMS, BY REGION, 2014–2021 (USD MILLION)
Table 7 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR FLUOROSCOPY SYSTEMS, BY REGION, 2014–2021 (USD MILLION)
Table 8 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR BIOPSY DEVICES, BY REGION, 2014–2021 (USD MILLION)
Table 9 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR OTHER DEVICES, BY REGION, 2014–2021 (USD MILLION)
Table 10 INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION)
Table 11 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR ANGIOGRAPHY, BY REGION, 2014–2021 (USD MILLION)
Table 12 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR ANGIOPLASTY, BY REGION, 2014–2021 (USD MILLION)
Table 13 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR BIOPSY AND DRAINAGE, BY REGION, 2014–2021 (USD MILLION)
Table 14 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR EMBOLIZATION, BY REGION, 2014–2021 (USD MILLION)
Table 15 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR THROMBOLYSIS, BY REGION, 2014–2021 (USD MILLION)
Table 16 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR VERTEBROPLASTY, BY REGION, 2014–2021 (USD MILLION)
Table 17 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR NEPHROSTOMY, BY REGION, 2014–2021 (USD MILLION)
Table 18 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR OTHER PROCEDURES, BY REGION, 2014–2021 (USD MILLION)
Table 19 INTERVENTIONAL RADIOLOGY MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 20 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR CARDIOLOGY APPLICATIONS, BY REGION, 2014–2021 (USD MILLION)
Table 21 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR UROLOGY & NEPHROLOGY APPLICATIONS, BY REGION, 2014–2021 (USD MILLION)
Table 22 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR ONCOLOGY APPLICATIONS, BY REGION, 2014–2021 (USD MILLION)
Table 23 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR GASTROENTEROLOGY APPLICATIONS, BY REGION, 2014–2021 (USD MILLION)
Table 24 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 2014–2021 (USD MILLION)
Table 25 INTERVENTIONAL RADIOLOGY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 26 NORTH AMERICA: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 27 NORTH AMERICA: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 28 NORTH AMERICA: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION)
Table 29 NORTH AMERICA: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 30 U.S.: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 31 U.S.: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION)
Table 32 U.S.: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 33 CANADA: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 34 CANADA: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION)
Table 35 CANADA: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 36 EUROPE: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 37 EUROPE: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 38 EUROPE: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION)
Table 39 EUROPE: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 40 GERMANY: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 41 GERMANY: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION)
Table 42 GERMANY: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 43 FRANCE: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 44 FRANCE: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION)
Table 45 FRANCE: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 46 U.K.: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 47 U.K.: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION)
Table 48 U.K.: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 49 ITALY: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 50 ITALY: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION)
Table 51 ITALY: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 52 ROE: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 53 ROE: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION)
Table 54 ROE: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 55 ASIA: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 56 ASIA: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION)
Table 57 ASIA: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 58 ROW: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 59 ROW: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION)
Table 60 ROW: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 61 RECENT PRODUCT LAUNCHES
Table 62 RECENT AGREEMENTS, COLLABORATIONS & PARTNERSHIPS
Table 63 RECENT APPROVALS
Table 64 RECENT EXPANSIONS
Table 65 RECENT ACQUISITIONS
Table 66 OTHER DEVELOPMENTS
Table 1 INTERVENTIONAL RADIOLOGY MARKET SUMMARY
Table 2 INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 3 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR MRI SYSTEMS, BY REGION, 2014–2021 (USD MILLION)
Table 4 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE FOR ULTRASOUND SYSTEMS, BY REGION, 2014–2021 (USD MILLION)
Table 5 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR CT SCANNERS, BY REGION, 2014–2021 (USD MILLION)
Table 6 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR ANGIOGRAPHY SYSTEMS, BY REGION, 2014–2021 (USD MILLION)
Table 7 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR FLUOROSCOPY SYSTEMS, BY REGION, 2014–2021 (USD MILLION)
Table 8 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR BIOPSY DEVICES, BY REGION, 2014–2021 (USD MILLION)
Table 9 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR OTHER DEVICES, BY REGION, 2014–2021 (USD MILLION)
Table 10 INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION)
Table 11 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR ANGIOGRAPHY, BY REGION, 2014–2021 (USD MILLION)
Table 12 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR ANGIOPLASTY, BY REGION, 2014–2021 (USD MILLION)
Table 13 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR BIOPSY AND DRAINAGE, BY REGION, 2014–2021 (USD MILLION)
Table 14 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR EMBOLIZATION, BY REGION, 2014–2021 (USD MILLION)
Table 15 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR THROMBOLYSIS, BY REGION, 2014–2021 (USD MILLION)
Table 16 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR VERTEBROPLASTY, BY REGION, 2014–2021 (USD MILLION)
Table 17 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR NEPHROSTOMY, BY REGION, 2014–2021 (USD MILLION)
Table 18 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR OTHER PROCEDURES, BY REGION, 2014–2021 (USD MILLION)
Table 19 INTERVENTIONAL RADIOLOGY MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 20 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR CARDIOLOGY APPLICATIONS, BY REGION, 2014–2021 (USD MILLION)
Table 21 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR UROLOGY & NEPHROLOGY APPLICATIONS, BY REGION, 2014–2021 (USD MILLION)
Table 22 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR ONCOLOGY APPLICATIONS, BY REGION, 2014–2021 (USD MILLION)
Table 23 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR GASTROENTEROLOGY APPLICATIONS, BY REGION, 2014–2021 (USD MILLION)
Table 24 INTERVENTIONAL RADIOLOGY MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 2014–2021 (USD MILLION)
Table 25 INTERVENTIONAL RADIOLOGY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 26 NORTH AMERICA: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 27 NORTH AMERICA: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 28 NORTH AMERICA: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION)
Table 29 NORTH AMERICA: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 30 U.S.: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 31 U.S.: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION)
Table 32 U.S.: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 33 CANADA: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 34 CANADA: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION)
Table 35 CANADA: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 36 EUROPE: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 37 EUROPE: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 38 EUROPE: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION)
Table 39 EUROPE: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 40 GERMANY: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 41 GERMANY: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION)
Table 42 GERMANY: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 43 FRANCE: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 44 FRANCE: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION)
Table 45 FRANCE: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 46 U.K.: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 47 U.K.: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION)
Table 48 U.K.: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 49 ITALY: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 50 ITALY: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION)
Table 51 ITALY: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 52 ROE: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 53 ROE: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION)
Table 54 ROE: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 55 ASIA: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 56 ASIA: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION)
Table 57 ASIA: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 58 ROW: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 59 ROW: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY PROCEDURE, 2014–2021 (USD MILLION)
Table 60 ROW: INTERVENTIONAL RADIOLOGY MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 61 RECENT PRODUCT LAUNCHES
Table 62 RECENT AGREEMENTS, COLLABORATIONS & PARTNERSHIPS
Table 63 RECENT APPROVALS
Table 64 RECENT EXPANSIONS
Table 65 RECENT ACQUISITIONS
Table 66 OTHER DEVELOPMENTS
LIST OF FIGURES
Figure 1 GLOBAL INTERVENTIONAL RADIOLOGY MARKET SEGMENTATION
Figure 2 RESEARCH DESIGN
Figure 3 INTERVENTIONAL RADIOLOGY MARKET: BOTTOM-UP APPROACH
Figure 4 TOP-DOWN APPROACH
Figure 5 DATA TRIANGULATION METHODOLOGY
Figure 6 MRI SYSTEM ARE EXPECTED TO BE THE FASTEST GROWING SEGMENT IN THE FORECAST PERIOD
Figure 7 ANGIOGRPAHY HAS THE LARGEST SHARE OF THE INTERVENTIONAL RADIOLOGY MARKET
Figure 8 CARDIOLOGY COMMAND THE LARGEST SHARE OF INTERVENTIONAL RADIOLOGY MARKET
Figure 9 NORTH AMERICA TO DOMINATE THE INTERVENTIONAL RADIOLOGY MARKET
Figure 10 RISING PREVALENCE OF CHRONIC DISEASES, THE KEY DRIVER OF MARKET GROWTH
Figure 11 MRI SYSTEMS PRODUCT SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2016
Figure 12 ASIA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 13 NORTH AMERICA AND EUROPE—MATURE MARKETS FOR INTERVENTIONAL RADIOLOGY
Figure 14 INTERVENTIONAL RADIOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS
Figure 15 INTERVENTIONAL RADIOLOGY: SUPPLY CHAIN ANALYSIS
Figure 16 INTERVENTIONAL RADIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
Figure 17 GLOBAL INCIDENCE OF CANCER, BY TYPE (2012–2035)
Figure 18 MRI SYSTEMS PRODUCTS SEGMENT TO DOMINATE THE INTERVENTIONAL RADIOLOGY MARKET DURING THE FORECAST PERIOD
Figure 19 ANGIOGRAPHY PROCEDURES SEGMENT TO DOMINATE THE INTERVENTIONAL RADIOLOGY MARKET IN 2016
Figure 20 CARDIOLOGY SEGMENT TO DOMINATE THE INTERVENTIONAL RADIOLOGY APPLICATIONS MARKET DURING THE FORECAST PERIOD
Figure 21 GLOBAL CANCER INCIDENCE, BY REGION, 2012-2020
Figure 22 NORTH AMERICA TO DOMINATE THE INTERVENTIONAL RADIOLOGY MARKET IN 2016
Figure 23 NORTH AMERICA: INTERVENTIONAL RADIOLOGY MARKET SNAPSHOT
Figure 24 MRI SYSTEMS SEGMENT TO HOLD LARGEST SHARE OF THE NORTH AMERICAN MARKET
Figure 25 EUROPE: INTERVENTIONAL RADIOLOGY MARKET SNAPSHOT
Figure 26 EUROPE: MRI SYSTEMS TO HOLD THE LARGEST MARKET SHARE, BY PRODUCT
Figure 27 ASIA: INTERVENTIONAL RADIOLOGY MARKET SNAPSHOT
Figure 28 MRI SYSTEMS, THE FASTEST-GROWING PRODUCT SEGMENT IN THE ASIAN MARKET
Figure 29 ROW: INTERVENTIONAL RADIOLOGY MARKET SNAPSHOT
Figure 30 MRI SYSTEMS TO DOMINATE THE ROW MARKET DURING THE FORECAST PERIOD
Figure 31 PRODUCT LAUNCHES, THE MOST ADOPTED GROWTH STRATEGY FROM 2013 TO 2016
Figure 32 GLOBAL INTERVENTIONAL RADIOLOGY MARKET SHARE, BY KEY PLAYER, 2015
Figure 33 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES WAS THE KEY STRATEGY PURSUED BY MARKET PLAYERS BETWEEN 2013 & 2016
Figure 34 GEOGRAPHIC REVENUE MIX OF TOP MARKET PLAYERS
Figure 35 GE HEALTHCARE: COMPANY SNAPSHOT (2015)
Figure 36 SIEMENS AG: COMPANY SNAPSHOT (2015)
Figure 37 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2015)
Figure 38 TOSHIBA MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2015)
Figure 39 HITACHI LTD: COMPANY SNAPSHOT (2015)
Figure 40 HOLOGIC INC.: COMPANY SNAPSHOT (2015)
Figure 41 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2015)
Figure 42 SAMSUNG ELECTRONICS: COMPANY SNAPSHOT (2015)
Figure 1 GLOBAL INTERVENTIONAL RADIOLOGY MARKET SEGMENTATION
Figure 2 RESEARCH DESIGN
Figure 3 INTERVENTIONAL RADIOLOGY MARKET: BOTTOM-UP APPROACH
Figure 4 TOP-DOWN APPROACH
Figure 5 DATA TRIANGULATION METHODOLOGY
Figure 6 MRI SYSTEM ARE EXPECTED TO BE THE FASTEST GROWING SEGMENT IN THE FORECAST PERIOD
Figure 7 ANGIOGRPAHY HAS THE LARGEST SHARE OF THE INTERVENTIONAL RADIOLOGY MARKET
Figure 8 CARDIOLOGY COMMAND THE LARGEST SHARE OF INTERVENTIONAL RADIOLOGY MARKET
Figure 9 NORTH AMERICA TO DOMINATE THE INTERVENTIONAL RADIOLOGY MARKET
Figure 10 RISING PREVALENCE OF CHRONIC DISEASES, THE KEY DRIVER OF MARKET GROWTH
Figure 11 MRI SYSTEMS PRODUCT SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2016
Figure 12 ASIA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 13 NORTH AMERICA AND EUROPE—MATURE MARKETS FOR INTERVENTIONAL RADIOLOGY
Figure 14 INTERVENTIONAL RADIOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS
Figure 15 INTERVENTIONAL RADIOLOGY: SUPPLY CHAIN ANALYSIS
Figure 16 INTERVENTIONAL RADIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
Figure 17 GLOBAL INCIDENCE OF CANCER, BY TYPE (2012–2035)
Figure 18 MRI SYSTEMS PRODUCTS SEGMENT TO DOMINATE THE INTERVENTIONAL RADIOLOGY MARKET DURING THE FORECAST PERIOD
Figure 19 ANGIOGRAPHY PROCEDURES SEGMENT TO DOMINATE THE INTERVENTIONAL RADIOLOGY MARKET IN 2016
Figure 20 CARDIOLOGY SEGMENT TO DOMINATE THE INTERVENTIONAL RADIOLOGY APPLICATIONS MARKET DURING THE FORECAST PERIOD
Figure 21 GLOBAL CANCER INCIDENCE, BY REGION, 2012-2020
Figure 22 NORTH AMERICA TO DOMINATE THE INTERVENTIONAL RADIOLOGY MARKET IN 2016
Figure 23 NORTH AMERICA: INTERVENTIONAL RADIOLOGY MARKET SNAPSHOT
Figure 24 MRI SYSTEMS SEGMENT TO HOLD LARGEST SHARE OF THE NORTH AMERICAN MARKET
Figure 25 EUROPE: INTERVENTIONAL RADIOLOGY MARKET SNAPSHOT
Figure 26 EUROPE: MRI SYSTEMS TO HOLD THE LARGEST MARKET SHARE, BY PRODUCT
Figure 27 ASIA: INTERVENTIONAL RADIOLOGY MARKET SNAPSHOT
Figure 28 MRI SYSTEMS, THE FASTEST-GROWING PRODUCT SEGMENT IN THE ASIAN MARKET
Figure 29 ROW: INTERVENTIONAL RADIOLOGY MARKET SNAPSHOT
Figure 30 MRI SYSTEMS TO DOMINATE THE ROW MARKET DURING THE FORECAST PERIOD
Figure 31 PRODUCT LAUNCHES, THE MOST ADOPTED GROWTH STRATEGY FROM 2013 TO 2016
Figure 32 GLOBAL INTERVENTIONAL RADIOLOGY MARKET SHARE, BY KEY PLAYER, 2015
Figure 33 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES WAS THE KEY STRATEGY PURSUED BY MARKET PLAYERS BETWEEN 2013 & 2016
Figure 34 GEOGRAPHIC REVENUE MIX OF TOP MARKET PLAYERS
Figure 35 GE HEALTHCARE: COMPANY SNAPSHOT (2015)
Figure 36 SIEMENS AG: COMPANY SNAPSHOT (2015)
Figure 37 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2015)
Figure 38 TOSHIBA MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2015)
Figure 39 HITACHI LTD: COMPANY SNAPSHOT (2015)
Figure 40 HOLOGIC INC.: COMPANY SNAPSHOT (2015)
Figure 41 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2015)
Figure 42 SAMSUNG ELECTRONICS: COMPANY SNAPSHOT (2015)
